Format

Send to

Choose Destination
Clin Infect Dis. 2017 Mar 15;64(suppl_1):S36-S40. doi: 10.1093/cid/ciw830.

The Role of Stewardship in Addressing Antibacterial Resistance: Stewardship and Infection Control Committee of the Antibacterial Resistance Leadership Group.

Author information

1
Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University Medical Center, Durham, North Carolina.
2
Division of Infectious Diseases, Denver Health, Colorado.
3
Center for Biostatistics in AIDS Research and the Department of Biostatistics, Harvard University, Boston, Massachusetts.
4
University of Maryland School of Medicine, Baltimore.
5
Rush University Medical Center, Chicago, Illinois.
6
Johns Hopkins University School of Medicine, Baltimore, Maryland.
7
Department of Medicine, Division of Infectious Diseases, University of Pennsylvania School of Medicine, Philadelphia.
8
Division of Pediatric Infectious Diseases.
9
Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, and.
10
Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota ; and.
11
Division of Infectious Diseases, Children's Hospital of Philadelphia, Pennsylvania.

Abstract

Antibacterial resistance is increasing globally and has been recognized as a major public health threat. Antibacterial stewardship is the coordinated effort to improve the appropriate use of antibiotics with the aim to decrease selective pressure for multidrug-resistant organisms in order to preserve the utility of antibacterial agents. This article describes the activities of the Antibacterial Resistance Leadership Group (ARLG) in the area of antibacterial stewardship. To date, the ARLG has focused intensely on development of rapid diagnostic tests, which (when coupled with educational and institutional initiatives) will enable the robust stewardship that is needed to address the current crisis of antibacterial resistance. In addition to exploring the effectiveness of stewardship techniques in community hospitals, the ARLG has also developed strategy trials to assess the feasibility of reducing antibacterial usage while preserving patient outcome.

KEYWORDS:

antibacterial resistance; infection control.; stewardship

PMID:
28350902
PMCID:
PMC5848301
DOI:
10.1093/cid/ciw830
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center